Physician profile

Neil L Starr

Prosthodontics · Washington, DC

NPI 1710026455

$1,416.58

in general payments reported to CMS, 2019-2025

13 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$50.13

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Straumann USA LLC $429.95 2020
Acteon INC $366.00 2022
Salvin Dental Specialties, INC. $164.14 2020
Ivoclar Vivadent, INC. $149.00 2019
Zimmer Biomet Holdings, INC. $125.00 2021
Nobel Biocare USA $35.19 2019
Ultradent Products INC $30.98 2021
Kuraray America INC. $30.85 2023
Kettenbach LP $27.99 2019
Envista Holdings Corporation $19.28 2024 Point 4
Dentsply Ih INC. $14.33 2019
Kulzer, LLC $12.13 2019
Philips North America LLC $11.74 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Neil L Starr

$1,416.58

in general payments reported 2019-2025

Years
2019-2024
Top company
Straumann USA LLC

https://glasscript.com/doctor/77306/neil-l-starr

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.